Clinical Scorecard: Comparative Study of Thulium Laser-Assisted Tumor Bed Coagulation and Traditional Suture Renorrhaphy in Laparoscopic Partial Nephrectomy: Effects on Perioperative Results and Fibrosis Biomarkers

At a Glance

Key Highlights

• Thulium laser-assisted LPN (LLPN) reduces warm ischemia time and parenchymal injury compared to conventional suture renorrhaphy (CLPN).
• Urinary fibrosis biomarkers (TGF-β1 and MCP-1) serve as indicators of renal fibrogenic response and functional decline post-PN.
• LLPN is feasible and safe for small exophytic renal tumors with potential benefits in preserving renal function and reducing fibrosis.

Guideline-Based Recommendations

Diagnosis

• Use contrast-enhanced abdominal CT for tumor characterization and staging.
• Assess renal function preoperatively via serum creatinine, eGFR (MDRD equation), and CKD staging (KDIGO criteria).
• Measure baseline urinary fibrosis biomarkers (TGF-β1 and MCP-1) on day of surgery.

Management

• Perform laparoscopic partial nephrectomy with selective renal artery clamping to minimize ischemia.
• Use 2-μm continuous thulium laser (80 W) for medullary tumor bed coagulation in LLPN.
• Close cortical layer with barbed sutures and hem-o-lok clips using sliding-clip technique in both LLPN and CLPN.
• Employ adjunctive hemostatic agents as needed and unclamp renal artery early after achieving hemostasis.

Monitoring & Follow-up

• Monitor complete blood count within 24 hours postoperatively.
• Assess renal function (serum creatinine, eGFR) and urinary fibrosis biomarkers (TGF-β1, MCP-1) on postoperative day 1, and at 1 and 3 months follow-up.
• Perform renal ultrasound postoperatively and contrast-enhanced CT at 3 months to evaluate for residual tumor or recurrence.
• Record and grade surgical complications using Clavien–Dindo classification.

Risks

• Prolonged warm ischemia time may increase parenchymal injury and fibrosis.
• Suture renorrhaphy may exacerbate chronic ischemia and fibrotic remodeling.
• Exclusion of patients with high surgical risk (ASA ≥ 3) or complex tumors (RENAL score > 9) to minimize complications.

Patient & Prescribing Data

Adults with clinical T1 small renal masses undergoing laparoscopic partial nephrectomy

Thulium laser-assisted coagulation reduces ischemia time and fibrogenic biomarker elevation compared to traditional suture renorrhaphy, potentially improving renal functional preservation.

Clinical Best Practices

• Select patients carefully excluding those with complex tumors or significant comorbidities.
• Use thulium laser coagulation for precise tumor bed hemostasis to minimize parenchymal damage.
• Implement early unclamping of renal artery once hemostasis is achieved to reduce ischemia time.
• Monitor urinary fibrosis biomarkers alongside renal function tests to assess fibrogenic response postoperatively.
• Standardize surgical technique and postoperative monitoring to optimize outcomes and detect complications early.

References

• ClinicalTrials.gov NCT06322745